Literature DB >> 24744848

Posterior reversible encephalopathy syndrome: differences between pregnant and non-pregnant patients.

Luiz Carlos Porcello Marrone1, Giovani Gadonski2, Luciano Passamani Diogo1, João Pedro Farina Brunelli1, William Alves Martins1, Gabriela de Oliveira Laguna1, Laura Fuchs Bahlis1, João Rubião Hoefel Filho3, Bartira Ercilia Pinheiro da Costa2, Carlos Eduardo Poli-de-Figueiredo2, Antônio Carlos Huf Marrone1, Jaderson Costa da Costa1.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a clinical-radiologic entity not yet understood, that presents with transient neurologic symptoms and particular radiological findings. Few papers show the differences between pregnant and non-pregnant patients. We review the cases of 38 women diagnosed with PRES, in order to find significant differences between pregnant (18) and non-pregnant (20) patients. We found differences among the age of patients (25.83 years old in pregnant and 29.31 years old in non pregnant; P=0.001); in the mean of highest systolic blood pressure, that was higher in non-pregnant group (185:162 mmHg; P=0.121); and in creatinine levels that was higher in non-pregnant group (3.47:1.04 mg/dL; P=0.001). To our knowledge, just a few papers analyzed whether PRES syndrome presented in the same way in pregnant and non-pregnant patients. The differences and the possible pathophisiology of this syndrome still remain enigmatic.

Entities:  

Keywords:  brain magnetic resonance image; cerebral autoregulation; eclampsia/pre-eclampsia; posterior reversible encephalopathy syndrome; reversible leukoencephalopathy

Year:  2014        PMID: 24744848      PMCID: PMC3980148          DOI: 10.4081/ni.2014.5376

Source DB:  PubMed          Journal:  Neurol Int        ISSN: 2035-8385


Introduction

Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologic entity characterized by headaches, altered mental status, seizures, and visual loss; it is associated with white matter vasogenic edema predominantly affecting the occipital and parietal lobes of the brain. The cause of PRES is not yet understood. Auto-regulatory failure with resultant vasodilation, as seen in hypertensive encephalopathy, is often cited as the underlying mechanism. On the other hand, vasospasm with ischemic change is also observed in some patients.[2,3] Several factors can trigger the syndrome, most commonly: acute elevation of blood pressure, abnormal renal function and immunosuppressive therapy. Other possible etiologies are eclampsia,[4-7] transplantation, neoplasia and chemotherapy treatment, systemic infections, renal disease acute or chronic.[11,12] The most characteristic imaging pattern in PRES is the presence of edema involving the white matter of the posterior portions of both cerebral hemispheres, especially the parietooccipital regions, in a relatively symmetric pattern that spares the calcarine and paramedian parts of the occipital lobes (Figure 1). However, other structures (such as the brain stem, cerebellum, and frontal and temporal lobes) may also be involved, and although the abnormality primarily affects the subcortical white matter, the cortex and the basal ganglia may also be involved.
Figure 1.

Brain magnetic resonance imaging (FLAIR) showing an increase of signal in both parieto-occipital lobes.

Pre-eclampsia (PE) is one of the most common situations described in association with PRES. PE is a multisystem disorder that complicates 3-8% of pregnancies in Western countries,[14,15] and has a complex pathophysiology. Defective invasion of the spiral arteries by cytotrophoblast cells is observed during preeclampsia. The crucial issue to understand is that the prime mover of PE is abnormal placentation. Two common theories appear to be interlinked, a genetic theory and an immunological theory. Clinical and laboratory tests are intended to define and determine the severity of PE. Headaches, tinnitus, visual disorders, brisk tendon reflexes, and vigilance disorders are related to cerebral edema; oliguria to acute renal failure; uterine contraction, vaginal bleeding to placental abruption; vomiting to HELLP syndrome (Hemolysis Elevated Liver enzymes Low Plaquet count); bandlike epigastric pain to subcapsular hepatic hematoma; and dyspnea to cardiac failure. Eclampsia, the major neurological complication of pre-eclampsia, is defined as a convulsive episode or any other sign of altered consciousness arising in a setting of PE, and which cannot be attributed to a pre-existing neurological condition. Delivery is the only curative treatment for PE.

Materials and Methods

We realized a study on 38 cases of PRES (18 pregnant and 20 non-pregnant patients), that were admitted to the Neurologic Service of Hospital São Lucas-PUCRS (Brazil) or that were assisted in other units of the same hospital by our services. All the patients underwent a brain magnetic resonance image (MRI): 36 patients (94.73%) were submitted to two brain MRI; 1 was submitted to one brain MRI plus one brain CT; and the other one realized only one exam. The following data was evaluated: age, sex, previous diseases and past medical history, use of medications, the neurologic manifestations, the highest blood pressure during the neurologic presentation, the highest creatinine during the period of observation and the neuroimage alterations in brain MRI. The highest blood pressure was measured during the 48 hours before the neurologic manifestation and the highest creatinine was analyzed during a mean period of two week before the neurologic manifestation. All the brain MRI were analyzed by a neurologist, who had no contact with the patient’s clinical data. We analyzed the data using the Statistical Package for the Social Sciences (SPSS). We applied Chi-square test or Exact Fischer test for comparing data with non-parametic distribution and the Student t test for comparison of means. A P value <0.05 was considered significant. All of the procedures and protocols executed in this study were approved by the Institutional Ethics Committee from Pontifícia Universidade Católica do Rio Grande do Sul.

Results

It was performed a review of 38 cases of patients with the diagnosis of PRES, that were assisted in Hospital São Lucas-PUCRS. Among this 38 cases, with mean age 25.11 years old (range from 2 to 74) and 78.9% of female, there were three children, that were excluded of some analyzes. The children were excluded of analyze of the creatinine and blood pressure, because in our opinion, their age didn’t premises us to include them in some evaluations (creatinine level and blood pressure). By the way, it was identified 34 patients (eighteen were pregnant or in puerperium period). The other group was composed by four patients with lupus, four with neoplasia in chemotherapy,[9,19] four with glomerulonephritis, two patients with hypertension, two patients in use of Tacrolimus after renal transplantation, two patients with Hemolitic Uremic syndrome, one after scorpion sting and one patient with alteration of renal function. The mean age of the group of pregnant patients was 25.83 years old and was 29.31 years old in the other group. The group of non-pregnant patients was composed by five men and eleven women. There was an important difference in the highest systolic blood pressure among both groups. In the non-pregnant group the mean highest systolic blood pressure was 185 mmHg and in the pregnant group was 162 mmHg, but without statistical diference. The mean creatinine was 3.47 mg/dL in the non-pregnant patients and was 1.04 mg/dL in the pregnant patients. The most common symptom was headache in both groups 78.8% overall (reported by 88.9% of the pregnant patients and 70% of non-pregnant patients); followed by visual disturbance 65.8% overall (66.7% of pregnant patients and 65% of non-pregnant patients); seizure 63.2% overall (50% in pregnant group and 75% in non-pregnant group) and mental status alteration (22% of pregnant patients and 52% of non-pregnant patients). The alterations in all patients and the neuroimaging findings are described in Table 1.
Table 1.

Differences among pregnant and non-pregnant patients.

PregnantNon-PregnantP
Age25.8329.310.001*
Highest systolic blood pressure, mmHg*1621850.121
Patients systolic blood pressure >160 mmHg, %66.7810.308
Patients systolic blood pressure >180 mmHg, %16.761.90.004*
Highest creatinine, mg/dL*1.043.470.001*
Headache (%)88.9 (16)70 (14)0.154
Seizure (%)50 (9)75 (15)0.111
Visual disturbance (%)66.7 (12)65 (13)0.914
Altered mental status (%)22 (4)55 (11)0.039*
Magnetic resonance findings (%) Occipital Parietal Frontal Temporal83.3 (15)55.6 (10)27.8 (5)22.2 (4)100 (20)65 (13)30 (6)30 (6)0.0570.5520.5650.587

*Patients with less than 12 years old were excluded of analysis.

Discussion and Conclusions

Since 1985, neuro-radiologic findings had been described in the presence of eclampsia and other pregnant dysfunctions. After its first description in 1996, many papers were published; however the precise pathophisiological mechanism remains unclear. In 2000, Casey et al. proposer the term Posterior Reversible Encephalopathy Syndrome. Few papers analyzed if the syndrome presented in pregnant patients was the same described in the other patients with PRES. In our group of patients, there was a difference in creatinine level; both of them with higher value in non-pregnant group. Even excluding the patient with renal disease (in case of creatinine level analyzes), the difference between the groups remains. In 2009, Roth explored the differences between pregnant patients and non pregnant patients in a very interesting paper. Studying 21 patients, Roth described few differences in both groups, like headache was more reported by pregnant patients (87.5%) than non-pregnant patients (30.8%) and visual disturbance that was also more reported in pregnant patients than in non-pregnant patients (75% vs 46.2%). In this study, the mean age of pregnant patients was 22 years old and was 49 years old in the group of non-pregnant patients. The blood pressures of both groups were very similar. Liman and colleagues performed the investigation of the mean arterial pressure in different groups of patients with PRES and found in infection (131 mmHg), auto-imunes disorders (123 mmHg), eclampsia (119 mmHg) and chemotherapy (110 mmHg). Liman also reported that preeclampsia-eclampsia patients had significantly less severe edema, less cytotoxic edema, hemorrhage and contrast enhancement, while more frequent complete resolution of edema and less frequent residual structural lesions were seen on follow-up imaging. PRES is commonly seen in the setting of hypertension; probably due to a breakdown of autoregulation. The autoregulation is an intrinsic function of the vasculature of the brain, designed to maintain a stable blood flow independent of the variation of blood pressure. In animal models, when a severe increase in blood pressure beyond the upper limit of autoregulation was caused, occur an arteriolar dilation, injury to the capillary bed, vasogenic edema and vessel injury with altered artery morphology. The upper limits of autoregulation range among the patients. This limits depends primary on the capillary hydrostatic pressure, under the influence of the systolic blood pressure, the integrity of blood-brain barrier and other situations (like medications). Evaluating the differences of blood pressure among pregnant and non-pregnant patients, we demonstrated that pregnant patients present breakdown of cerebral autoregulation with lower mean arterial blood pressure. We speculate that the pregnant patients had different triggers of the other patients and the fact of the delivery is the curative treatment for PE can represent the finish of the stimulus for the brain vasogenic edema. Is it the reason that causes differences in the pregnant patients when compared with non-pregnant patients? This paper contributes showing differences of blood pressure and creatinine in this both groups. The precise pathophysiology mechanism of this syndrome remains enigmatic.
  25 in total

1.  Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

Authors:  S O Casey; R C Sampaio; E Michel; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

Review 2.  Preeclampsia and future maternal health.

Authors:  David M Carty; Christian Delles; Anna F Dominiczak
Journal:  J Hypertens       Date:  2010-07       Impact factor: 4.844

3.  CT and angiographic correlation of severe neurological disease in toxemia of pregnancy.

Authors:  L K Lewis; D B Hinshaw; A D Will; A N Hasso; J R Thompson
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

4.  Clinical and radiological differences in posterior reversible encephalopathy syndrome between patients with preeclampsia-eclampsia and other predisposing diseases.

Authors:  T G Liman; G Bohner; P U Heuschmann; M Scheel; M Endres; E Siebert
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

Review 5.  Posterior reversible encephalopathy syndrome: a review.

Authors:  Steven K Feske
Journal:  Semin Neurol       Date:  2011-05-17       Impact factor: 3.420

6.  Toxemia of pregnancy: cerebral CT findings.

Authors:  M H Naheedy; J Biller; M Schiffer; B Azar-Kia; J Gianopoulous; S Zarandy
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

Review 7.  The global impact of pre-eclampsia and eclampsia.

Authors:  Lelia Duley
Journal:  Semin Perinatol       Date:  2009-06       Impact factor: 3.300

8.  Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions.

Authors:  Richard B Schwartz
Journal:  Neurologist       Date:  2002-01       Impact factor: 1.398

Review 9.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19

10.  Posterior Reversible Encephalopathy Syndrome Associated with FOLFOX Chemotherapy.

Authors:  Luiz Carlos Porcello Marrone; Bianca Fontana Marrone; Tharick Ali Pascoal; Lucas Porcello Schilling; Ricardo Bernardi Soder; Sheila Schuch Ferreira; Giovani Gadonski; Jaderson Costa da Costa
Journal:  Case Rep Oncol Med       Date:  2013-02-27
View more
  10 in total

Review 1.  Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2017-05       Impact factor: 5.606

2.  Effect of blood pressure on reversible posterior leukoencephalopathy syndrome in pre-eclampsia or eclampsia.

Authors:  Fang Xiaobo; Liang Yanling; Chen Dunjin; He Fang; Chen Jia; Zhong Yuhua; Zhang Weixi
Journal:  Hypertens Res       Date:  2017-11-02       Impact factor: 3.872

3.  A study on clinicoradiological characteristics and pregnancy outcomes of reversible posterior leukoencephalopathy syndrome in preeclampsia or eclampsia.

Authors:  Xiaobo Fang; Yanling Liang; Dunjin Chen; Fang He; Jia Chen; Fami Huang
Journal:  Hypertens Res       Date:  2017-09-07       Impact factor: 3.872

4.  Posterior reversible encephalopathy syndrome, preeclampsia or stroke? A diagnostic dilemma.

Authors:  Vikesh Patel; Bhavna Ramachandran; Ifrah Omar
Journal:  BMJ Case Rep       Date:  2019-07-27

5.  Serum Neurofilament Light: a Potential Diagnostic and Prognostic Biomarker in Obstetric Posterior Reversible Encephalopathy Syndrome.

Authors:  Xiaobo Fang; Yanling Liang; Weixi Zhang; Qiong Wang; Jingsi Chen; Jia Chen; Yongqiang Lin; Yanli Chen; Li Yu; Haibin Wang; Dunjin Chen
Journal:  Mol Neurobiol       Date:  2021-09-22       Impact factor: 5.590

6.  Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome.

Authors:  William Alves Martins; Luiz Carlos Porcello Marrone
Journal:  J Clin Neurol       Date:  2015-11-04       Impact factor: 3.077

7.  Delayed diagnosis of PRES and eclampsia in a concealed pregnancy.

Authors:  Zeynep Ozcan Dag; Yavuz Simsek; Yakup Turkel; Ozlem Banu Tulmac; Yuksel Isik
Journal:  Pan Afr Med J       Date:  2014-11-18

8.  An unusual case of posterior reversible encephalopathy syndrome in a patient being weaned from intrathecal morphine.

Authors:  Jasper Van Aalst; Onno P Teernstra; Wim E Weber; Kim Rijkers
Journal:  Int Med Case Rep J       Date:  2016-05-17

9.  Atypical case of posterior reversible encephalopathy syndrome related to late onset postpartum eclampsia: A case report.

Authors:  Kaori Masai; Yayoi Ueda; Hiromichi Naito; Kohei Tsukahara; Toshiyuki Aokage; Noritomo Fujisaki; Hirotsugu Yamamoto; Atsunori Nakao
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 10.  Reversible posterior leukoencephalopathy syndrome due to adrenal pheochromocytoma: A case report and literature review.

Authors:  Bo Han; Yi Li; Maozhi Tang; Shun Wu; Xiaosong Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.